Covaxin Gets Emergency Use Nod For Children Aged 2-18 Years

NEW DELHI, Oct 12: Subject Expert Committee of the drug regulator has recommended granting an emergency use authorisation to Bharat Biotech's Covaxin for children aged between 2-18. 

The SEC has submitted its recommendation to the Drugs Controller General of India (DCGI) for final approval.

“After detailed deliberation, the committee recommended for grant of market authorization of the vaccine for the age group of 2 to 18 years for restricted use in an emergency situation," the expert panel said in a statement.

 

Comments

Cross Town News is the no. 1 Weekly Newspaper and Online News Portal in J&K in term of serious News. The rugged Newspaper & Portal is with a substantial difference to read and presence to feel. This newspaper has a vision to deliver the real side of truth to the public . Since it’s inception in 2013 March, It has become No. 1 News medium for people of J&K. Cross Town News has a mission to deliver high quality news across the nation within fraction of time.

Subscribe Now

Subscribe to our weekly Newsletter.